Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1372 of 6351
-
New hope for kids with weak hearts: long-term safety study launched
Disease control Recruiting nowResearchers are looking for a better way to treat children and young adults who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure with left ventricular systolic dysfunction (LVSD) is a condition where the left side of the heart is weak and strugg…
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill shows promise for rare blood disorder in Long-Term trial
Disease control Not yet recruitingNTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, open-label study evaluating the long-term efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinuria
Phase 3 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 17:40 UTC
-
New hope for rare bleeding disorder: coagadex trial targets AL amyloidosis
Disease control CancelledThe purpose of this study is to evaluate the efficacy and safety of Coagadex in treating active bleeds and to manage peri-operative bleeding in participants with acquired factor X deficiency associated with AL amyloidosis.
Phase 3 • Sponsor: Kedrion S.p.A. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Gene secrets could explain why heart drug works for some, not others
Knowledge-focused Not yet recruitingThis research study, aims to understand why a specific heart medication called mavacamten works better for some people with hypertrophic cardiomyopathy (HCM) than for others. We believe the answer might be in our genes. The study focuses on two key areas: 1. The specific gene c…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Liver cirrhosis bleeding: which procedure wins?
Disease control Not yet recruitingThis study aims to compare two treatments for cirrhotic portal hypertension with acute esophagogastric variceal bleeding and hypersplenism: laparoscopic splenectomy and azygoportal disconnection (LSD) and transjugular intrahepatic portosystemic shunt (TIPS). It is a single-center…
Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Smartphone app aims to stop pregnancy diabetes before it starts
Prevention Not yet recruitingThis study aims to develop and evaluate an early risk identification and digital health intervention strategy for gestational diabetes mellitus (GDM) among pregnant women in China. Gestational diabetes mellitus is a common pregnancy complication associated with adverse maternal a…
Sponsor: Peking University • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New hope for ulcerative colitis patients who failed biologics?
Disease control Not yet recruitingThe primary objective of this trial is to evaluate the clinical efficacy of ATH-063 in participants with biologic/advanced therapy relapsed/refractory moderately to severely active UC.
Phase 2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New wearable device aims to unfreeze Parkinson's patients in their tracks
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the ParkinSense system, a customizable, multimodal, and adaptable cueing system, can assist with freezing of gait (FOG) in patients with Parkinson's disease. The main question it aims to answer is: is the percent of time spent frozen…
Sponsor: Barron Associates, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New scan could spot hidden heart risk in kidney patients
Diagnosis Not yet recruitingPatients with chronic kidney disease (CKD) have a markedly increased cardiovascular risk, with coronary artery disease being a leading cause of morbidity and mortality. Conventional cardiovascular risk scores and non-invasive diagnostic tests have limited accuracy in this populat…
Sponsor: University Hospital, Grenoble • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Light therapy offers hope for kids suffering chemo mouth sores
Symptom relief Not yet recruitingChemotherapy induced oral mucositis is a common and debilitating complication in pediatric patients receiving chemotherapy for hematolymphoid malignancies. Oral mucositis can cause painful mouth ulcers, difficulty in eating and drinking, impaired nutrition, increased risk of infe…
Sponsor: Tata Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can CBD or a nerve zap ease Athletes' Post-Concussion headaches?
Symptom relief Not yet recruitingDo cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?
Phase 2 • Sponsor: American Society of Pain and Neuroscience, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Blood thinner may stop organ failure in pancreatitis patients
Disease control Not yet recruitingThis clinical trial is designed to evaluate whether adding a standard blood-thinning medication, Unfractionated Heparin, to standard hospital care can help prevent severe organ failure in patients admitted with acute pancreatitis. Acute pancreatitis is a sudden and severe inflam…
Phase 4 • Sponsor: Allied Hospital Faisalabad • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can an ancient herbal remedy tame rheumatoid arthritis?
Disease control Recruiting nowRheumatoid Arthritis (RA) is a chronic disease characterised by symmetric, polyarticular pain and swelling, involving small joints of the hands and feet. RA can lead to irreversible joint damage without treatment, causing disability and impacting daily activities and work product…
Phase 2/3 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New ultrasound technique may predict chemo success after just one dose
Diagnosis Not yet recruiting1. Study Design Overview Study Type: Single-center, prospective, observational, diagnostic study. Primary Objective: To validate whether Super-Resolution Ultrasound Imaging (SRUS) can accurately predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in bre…
Sponsor: Anhui Provincial Cancer Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New digital program aims to ease migraine pain without drugs
Symptom relief Recruiting nowThis study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exercise therapy, and a dedicated care team, in reducing migraine frequency among a…
Sponsor: Hinge Health, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Shoulder surgery upgrade: using your own biceps tendon to prevent Re-Tears
Disease control Not yet recruitingThe goal of this clinical trial is to reduce the risk for re-tear in rotator cuff surgeries and improve clinical results in a working age population. The main questions it aims to answer are: If we can improve surgical results using the long head of the biceps tendon as a graft.…
Sponsor: HOSPITAL FRATERNIDAD MUPRESPA HABANA • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThe purpose of this clinical trial is to learn how well ACT-777991 works, how safe it is and how well it is tolerated by adults with non-segmental vitiligo. The main question this clinical trial aims to answer is: • Can ACT-777991 help return color to the skin of the face of ad…
Phase 2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple inhaled antibiotic stop deadly pneumonia in ventilator patients?
Disease control Not yet recruitingThe primary objective of the AMIVAT trial is to assess whether a 5-day course of inhaled amikacin, compared to placebo, reduces the incidence of progression to ventilator-associated pneumonia (VAP) at day 28 in intensive care unit (ICU) patients with ventilator-associated tracheo…
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Blood test may personalize leukemia drug dosing
Knowledge-focused Recruiting nowVenetoclax combined with azacitidine (VEN-AZA) is the current first-line standard of care for newly diagnosed acute myeloid leukemia (AML) patients unfit for intensive chemotherapy. Although this regimen substantially improves remission rates, marked inter-individual variability …
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Blood clue may predict brain fog after surgery in seniors
Knowledge-focused Not yet recruitingThe term perioperative neurocognitive disorders (PND) is derived from postoperative cognitive dysfunction (POCD), and has been renamed as PND in recent years in accordance with the latest international consensus. PND specifically refers to changes in mental, social and cognitive …
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC